These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36456852)

  • 1. Pharmacokinetics of Long-Acting Aqueous Nano-/Microsuspensions After Intramuscular Administration in Different Animal Species and Humans-a Review.
    Nguyen VTT; Darville N; Vermeulen A
    AAPS J; 2022 Dec; 25(1):4. PubMed ID: 36456852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension.
    Darville N; van Heerden M; Mariën D; De Meulder M; Rossenu S; Vermeulen A; Vynckier A; De Jonghe S; Sterkens P; Annaert P; Van den Mooter G
    J Control Release; 2016 May; 230():95-108. PubMed ID: 27067365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking
    Nguyen V; Bevernage J; Darville N; Tistaert C; Van Bocxlaer J; Rossenu S; Vermeulen A
    Mol Pharm; 2021 Mar; 18(3):952-965. PubMed ID: 33400546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano- and microcrystals of griseofulvin subcutaneously administered to rats resulted in improved bioavailability and sustained release.
    Sigfridsson K; Rydberg H; Strimfors M
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1477-1486. PubMed ID: 31260340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Langmuir-Blodgett trough (Langmuir film balance) can be used to understand the stabilizer concentrations in aqueous nano- and microsuspensions.
    Zulbeari N; Mustafova SS; Simonsen AC; Lund FW; Holm R
    Int J Pharm; 2024 Nov; 665():124726. PubMed ID: 39293577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Formulation Parameters on In Vitro Release from Long-Acting Injectable Suspensions.
    Bao Q; Zou Y; Wang Y; Choi S; Burgess DJ
    AAPS J; 2021 Mar; 23(2):42. PubMed ID: 33709196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A candidate drug administered subcutaneously to rodents as drug particles showing hepatic recirculation which influenced the sustained release process.
    Sigfridsson K; Arvidsson T; Xue A; Wagner DJ; Pop-Damkov P; Zhang G; Strimfors M
    Int J Pharm; 2020 May; 581():119252. PubMed ID: 32240808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of different formulation strategies for sustained release injectables of a poorly soluble HIV protease inhibitor.
    Meeus J; Scurr DJ; Amssoms K; Wuyts K; Annaert P; Davies MC; Roberts CJ; Van den Mooter G
    J Control Release; 2015 Feb; 199():1-9. PubMed ID: 25485732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular administration of paliperidone palmitate extended-release injectable microsuspension induces a subclinical inflammatory reaction modulating the pharmacokinetics in rats.
    Darville N; van Heerden M; Vynckier A; De Meulder M; Sterkens P; Annaert P; Van den Mooter G
    J Pharm Sci; 2014 Jul; 103(7):2072-2087. PubMed ID: 24845884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Analysis of Preclinical and Clinical Pharmacokinetics from Administration of Long-Acting Aqueous Suspensions.
    Johnson AR; Ballard JE; Leithead A; Miller C; Faassen F; Zang X; Nofsinger R; Wagner AM
    Pharm Res; 2023 Jul; 40(7):1641-1656. PubMed ID: 36720831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscularly injected long-acting testosterone-cholesterol prodrug suspension with three different particle sizes: extended in vitro release and enhanced in vivo safety.
    Li S; Wang Z; Yu J; Zhang C; Ye J; Liu H; Jiang Y; He Z; Wang Y
    Drug Deliv Transl Res; 2024 Apr; 14(4):1093-1105. PubMed ID: 37932630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ramizol
    Wright L; Rao S; Thomas N; Boulos RA; Prestidge CA
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1451-1457. PubMed ID: 29619851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of solid lipid nanoparticles as a long-term drug delivery platform for intramuscular and subcutaneous administration: In vitro and in vivo evaluation.
    Elbrink K; Van Hees S; Chamanza R; Roelant D; Loomans T; Holm R; Kiekens F
    Eur J Pharm Biopharm; 2021 Jun; 163():158-170. PubMed ID: 33848628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolonged-release drug formulations for parenteral administration. Part l. Suspensions and oily solutions for injection].
    Płaczek M; Jacyna J; Sznitowska M
    Pol Merkur Lekarski; 2013 Dec; 35(210):391-6. PubMed ID: 24490472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of in vitro-in vivo correlations for long-acting injectable suspensions.
    Bao Q; Wang X; Wan B; Zou Y; Wang Y; Burgess DJ
    Int J Pharm; 2023 Mar; 634():122642. PubMed ID: 36709013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oily nanosuspension for long-acting intramuscular delivery of curcumin didecanoate prodrug: preparation, characterization and in vivo evaluation.
    Wei XL; Han YR; Quan LH; Liu CY; Liao YH
    Eur J Pharm Sci; 2013 May; 49(2):286-93. PubMed ID: 23542494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Acting Ionically Paired Pamoate-based Suspension of Lurasidone: An exploration of Size Effects on in vitro Dissolution and in vivo Pharmacokinetic Behaviors.
    Li S; He Y; Sun D; Wang Z; Yu J; Ye J; He Z; Wang Y
    AAPS PharmSciTech; 2023 Mar; 24(4):83. PubMed ID: 36949377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploitation of enrofloxacin-loaded docosanoic acid solid lipid nanoparticle suspension as oral and intramuscular sustained release formulations for pig.
    Tao Y; Yang F; Meng K; Chen D; Yang Y; Zhou K; Luo W; Qu W; Pan Y; Yuan Z; Xie S
    Drug Deliv; 2019 Dec; 26(1):273-280. PubMed ID: 30880494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creation of a ready-to-use brexpiprazole suspension and the inflammation-mediated pharmacokinetics by intramuscular administration.
    Wang J; Liu J; Ding J; Li Q; Zhao Y; Gao D; Su K; Yang Y; Wang Z; He J
    Eur J Pharm Biopharm; 2023 Aug; 189():189-201. PubMed ID: 37364749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting
    Rudd ND; Reibarkh M; Fang R; Mittal S; Walsh PL; Brunskill APJ; Forrest WP
    Mol Pharm; 2020 May; 17(5):1734-1747. PubMed ID: 32267708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.